PERIOPERATIVE ADVERSE OUTCOMES IN PATIENTS WITH ATRIAL FIBRILLATION TAKING EDOXABAN OR WARFARIN: ANALYSIS OF THE ENGAGE AF-TIMI 48 TRIAL

PERIOPERATIVE ADVERSE OUTCOMES IN PATIENTS WITH ATRIAL FIBRILLATION TAKING EDOXABAN OR WARFARIN: ANALYSIS OF THE ENGAGE AF-TIMI 48 TRIAL

Methods: We studied consecutive patients in ENGAGE, a randomized double-blind trial comparing edoxaban (30 and 60 mg QD) with warfarin for stroke prevention in AF, who had a first surgery/procedure.

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of the American College of Cardiology 2015-03, Vol.65 (10), p.A2092-A2092
Hauptverfasser: Douketis, James, Weitz, Jeffrey, Murphy, Sabina, Deenadayalu, Naveen, Crompton, Andrea Elizabeth, Mercuri, Michele, Ruff, Christian, Antman, Elliott, Giugliano, Robert
Format: Artikel
Sprache:eng
Schlagworte:
Anticoagulants
Cardiac arrhythmia
Cardiology
Cardiovascular
Drug therapy
Internal Medicine
Surgery
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page A2092
container_issue 10
container_start_page A2092
container_title Journal of the American College of Cardiology
container_volume 65
creator Douketis, James
Weitz, Jeffrey
Murphy, Sabina
Deenadayalu, Naveen
Crompton, Andrea Elizabeth
Mercuri, Michele
Ruff, Christian
Antman, Elliott
Giugliano, Robert
description Methods: We studied consecutive patients in ENGAGE, a randomized double-blind trial comparing edoxaban (30 and 60 mg QD) with warfarin for stroke prevention in AF, who had a first surgery/procedure.
doi_str_mv 10.1016/S0735-1097(15)62092-7
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_1675991484</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S0735109715620927</els_id><sourcerecordid>3666778591</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2847-2038ac46bcf407d2127c79cb1449d979bbe2f4cc2313bd52ce386f0ad590cd4d3</originalsourceid><addsrcrecordid>eNqFkM9u1DAQxq0KpC6FR6hkiUs5BGzHjmMORe7W2bVIkypx_3CyEseRUpbdErdIfQMem-wuolIvXGYO832_mfkAOMboI0Y4-VQjHrMII8FPMPuQECRIxA_ADDOWRjET_BWY_ZMcgjch3CGEkhSLGfh9qSpdTkUafa2gPL9WVa1geWXm5YWqoS7g5TRShanhjTZLKE2lZQ4zfVbpPJ9GZQGN_KqLBVTn5a08kwUsK3gjq0xWuvgMZSHzb7WuYZlBs1RQFQu5mDZlkdEXGtIU7ohvweu-WQX_7m8_AleZMvNllJcLPZd55EhKeURQnDaOJq3rKeIdwYQ7LlyLKRWd4KJtPempcyTGcdsx4nycJj1qOiaQ62gXH4H3e-79uPn56MODvds8jutppcUJZ0JgmtJJxfYqN25CGH1v78fhRzM-WYzsNnS7C91uE7WY2V3olk--L3ufn174NfjRBjf4tfPdMHr3YLvN8F_C6QuCWw3rwTWr7_7Jh-djbSAW7SFbBmY7Ao__AKxmkgk</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1675991484</pqid></control><display><type>article</type><title>PERIOPERATIVE ADVERSE OUTCOMES IN PATIENTS WITH ATRIAL FIBRILLATION TAKING EDOXABAN OR WARFARIN: ANALYSIS OF THE ENGAGE AF-TIMI 48 TRIAL</title><source>Elsevier ScienceDirect Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>Douketis, James ; Weitz, Jeffrey ; Murphy, Sabina ; Deenadayalu, Naveen ; Crompton, Andrea Elizabeth ; Mercuri, Michele ; Ruff, Christian ; Antman, Elliott ; Giugliano, Robert</creator><creatorcontrib>Douketis, James ; Weitz, Jeffrey ; Murphy, Sabina ; Deenadayalu, Naveen ; Crompton, Andrea Elizabeth ; Mercuri, Michele ; Ruff, Christian ; Antman, Elliott ; Giugliano, Robert</creatorcontrib><description>Methods: We studied consecutive patients in ENGAGE, a randomized double-blind trial comparing edoxaban (30 and 60 mg QD) with warfarin for stroke prevention in AF, who had a first surgery/procedure.</description><identifier>ISSN: 0735-1097</identifier><identifier>EISSN: 1558-3597</identifier><identifier>DOI: 10.1016/S0735-1097(15)62092-7</identifier><language>eng</language><publisher>New York: Elsevier Inc</publisher><subject>Anticoagulants ; Cardiac arrhythmia ; Cardiology ; Cardiovascular ; Drug therapy ; Internal Medicine ; Surgery</subject><ispartof>Journal of the American College of Cardiology, 2015-03, Vol.65 (10), p.A2092-A2092</ispartof><rights>American College of Cardiology Foundation</rights><rights>2015 American College of Cardiology Foundation</rights><rights>Copyright Elsevier Limited Mar 17, 2015</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c2847-2038ac46bcf407d2127c79cb1449d979bbe2f4cc2313bd52ce386f0ad590cd4d3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0735109715620927$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65534</link.rule.ids></links><search><creatorcontrib>Douketis, James</creatorcontrib><creatorcontrib>Weitz, Jeffrey</creatorcontrib><creatorcontrib>Murphy, Sabina</creatorcontrib><creatorcontrib>Deenadayalu, Naveen</creatorcontrib><creatorcontrib>Crompton, Andrea Elizabeth</creatorcontrib><creatorcontrib>Mercuri, Michele</creatorcontrib><creatorcontrib>Ruff, Christian</creatorcontrib><creatorcontrib>Antman, Elliott</creatorcontrib><creatorcontrib>Giugliano, Robert</creatorcontrib><title>PERIOPERATIVE ADVERSE OUTCOMES IN PATIENTS WITH ATRIAL FIBRILLATION TAKING EDOXABAN OR WARFARIN: ANALYSIS OF THE ENGAGE AF-TIMI 48 TRIAL</title><title>Journal of the American College of Cardiology</title><description>Methods: We studied consecutive patients in ENGAGE, a randomized double-blind trial comparing edoxaban (30 and 60 mg QD) with warfarin for stroke prevention in AF, who had a first surgery/procedure.</description><subject>Anticoagulants</subject><subject>Cardiac arrhythmia</subject><subject>Cardiology</subject><subject>Cardiovascular</subject><subject>Drug therapy</subject><subject>Internal Medicine</subject><subject>Surgery</subject><issn>0735-1097</issn><issn>1558-3597</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><recordid>eNqFkM9u1DAQxq0KpC6FR6hkiUs5BGzHjmMORe7W2bVIkypx_3CyEseRUpbdErdIfQMem-wuolIvXGYO832_mfkAOMboI0Y4-VQjHrMII8FPMPuQECRIxA_ADDOWRjET_BWY_ZMcgjch3CGEkhSLGfh9qSpdTkUafa2gPL9WVa1geWXm5YWqoS7g5TRShanhjTZLKE2lZQ4zfVbpPJ9GZQGN_KqLBVTn5a08kwUsK3gjq0xWuvgMZSHzb7WuYZlBs1RQFQu5mDZlkdEXGtIU7ohvweu-WQX_7m8_AleZMvNllJcLPZd55EhKeURQnDaOJq3rKeIdwYQ7LlyLKRWd4KJtPempcyTGcdsx4nycJj1qOiaQ62gXH4H3e-79uPn56MODvds8jutppcUJZ0JgmtJJxfYqN25CGH1v78fhRzM-WYzsNnS7C91uE7WY2V3olk--L3ufn174NfjRBjf4tfPdMHr3YLvN8F_C6QuCWw3rwTWr7_7Jh-djbSAW7SFbBmY7Ao__AKxmkgk</recordid><startdate>20150317</startdate><enddate>20150317</enddate><creator>Douketis, James</creator><creator>Weitz, Jeffrey</creator><creator>Murphy, Sabina</creator><creator>Deenadayalu, Naveen</creator><creator>Crompton, Andrea Elizabeth</creator><creator>Mercuri, Michele</creator><creator>Ruff, Christian</creator><creator>Antman, Elliott</creator><creator>Giugliano, Robert</creator><general>Elsevier Inc</general><general>Elsevier Limited</general><scope>6I.</scope><scope>AAFTH</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>7TK</scope><scope>H94</scope><scope>K9.</scope><scope>NAPCQ</scope></search><sort><creationdate>20150317</creationdate><title>PERIOPERATIVE ADVERSE OUTCOMES IN PATIENTS WITH ATRIAL FIBRILLATION TAKING EDOXABAN OR WARFARIN: ANALYSIS OF THE ENGAGE AF-TIMI 48 TRIAL</title><author>Douketis, James ; Weitz, Jeffrey ; Murphy, Sabina ; Deenadayalu, Naveen ; Crompton, Andrea Elizabeth ; Mercuri, Michele ; Ruff, Christian ; Antman, Elliott ; Giugliano, Robert</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2847-2038ac46bcf407d2127c79cb1449d979bbe2f4cc2313bd52ce386f0ad590cd4d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Anticoagulants</topic><topic>Cardiac arrhythmia</topic><topic>Cardiology</topic><topic>Cardiovascular</topic><topic>Drug therapy</topic><topic>Internal Medicine</topic><topic>Surgery</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Douketis, James</creatorcontrib><creatorcontrib>Weitz, Jeffrey</creatorcontrib><creatorcontrib>Murphy, Sabina</creatorcontrib><creatorcontrib>Deenadayalu, Naveen</creatorcontrib><creatorcontrib>Crompton, Andrea Elizabeth</creatorcontrib><creatorcontrib>Mercuri, Michele</creatorcontrib><creatorcontrib>Ruff, Christian</creatorcontrib><creatorcontrib>Antman, Elliott</creatorcontrib><creatorcontrib>Giugliano, Robert</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Premium</collection><jtitle>Journal of the American College of Cardiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Douketis, James</au><au>Weitz, Jeffrey</au><au>Murphy, Sabina</au><au>Deenadayalu, Naveen</au><au>Crompton, Andrea Elizabeth</au><au>Mercuri, Michele</au><au>Ruff, Christian</au><au>Antman, Elliott</au><au>Giugliano, Robert</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>PERIOPERATIVE ADVERSE OUTCOMES IN PATIENTS WITH ATRIAL FIBRILLATION TAKING EDOXABAN OR WARFARIN: ANALYSIS OF THE ENGAGE AF-TIMI 48 TRIAL</atitle><jtitle>Journal of the American College of Cardiology</jtitle><date>2015-03-17</date><risdate>2015</risdate><volume>65</volume><issue>10</issue><spage>A2092</spage><epage>A2092</epage><pages>A2092-A2092</pages><issn>0735-1097</issn><eissn>1558-3597</eissn><abstract>Methods: We studied consecutive patients in ENGAGE, a randomized double-blind trial comparing edoxaban (30 and 60 mg QD) with warfarin for stroke prevention in AF, who had a first surgery/procedure.</abstract><cop>New York</cop><pub>Elsevier Inc</pub><doi>10.1016/S0735-1097(15)62092-7</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0735-1097
ispartof Journal of the American College of Cardiology, 2015-03, Vol.65 (10), p.A2092-A2092
issn 0735-1097
1558-3597
language eng
recordid cdi_proquest_journals_1675991484
source Elsevier ScienceDirect Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection
subjects Anticoagulants
Cardiac arrhythmia
Cardiology
Cardiovascular
Drug therapy
Internal Medicine
Surgery
title PERIOPERATIVE ADVERSE OUTCOMES IN PATIENTS WITH ATRIAL FIBRILLATION TAKING EDOXABAN OR WARFARIN: ANALYSIS OF THE ENGAGE AF-TIMI 48 TRIAL
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-19T00%3A54%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=PERIOPERATIVE%20ADVERSE%20OUTCOMES%20IN%20PATIENTS%20WITH%20ATRIAL%20FIBRILLATION%20TAKING%20EDOXABAN%20OR%20WARFARIN:%20ANALYSIS%20OF%20THE%20ENGAGE%20AF-TIMI%2048%20TRIAL&rft.jtitle=Journal%20of%20the%20American%20College%20of%20Cardiology&rft.au=Douketis,%20James&rft.date=2015-03-17&rft.volume=65&rft.issue=10&rft.spage=A2092&rft.epage=A2092&rft.pages=A2092-A2092&rft.issn=0735-1097&rft.eissn=1558-3597&rft_id=info:doi/10.1016/S0735-1097(15)62092-7&rft_dat=%3Cproquest_cross%3E3666778591%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1675991484&rft_id=info:pmid/&rft_els_id=1_s2_0_S0735109715620927&rfr_iscdi=true